Save
Upgrade to remove ads
Busy. Please wait.
Log in with Clever
or

show password
Forgot Password?

Don't have an account?  Sign up 
Sign up using Clever
or

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
Your email address is only used to allow you to reset your password. See our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
focusNode
Didn't know it?
click below
 
Knew it?
click below
Don't Know
Remaining cards (0)
Know
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

WEEK 7:

Experimenting on people- RCTs:

QuestionAnswer
randomised controlled trial planned experiment involving patients and is designed to elucidate most appropriate method of treatment of future patients with a given medical condition
difference in outcome only due to intervention (so can establish causation)
key design features of RCTs (4) choosing a control treatment, randomisation to study group, allocation concealment, and blinding
control group includes (2) standard treatment (is new treatment better than old) and placebo (does treatment work at all or better than placebo)
placebo an inert substance which looks, tastes and is packaged identically to the comparison substance
placebo effect A beneficial effect produced by a placebo drug or treatment, which cannot be attributed to the properties of the placebo itself, and must therefore be due to the patient's belief in that treatment
nocebo effect reversed placebo effect - expectation of negative effects increases likelihood of unpleasant sensations
how do RCTs remove selection bias equal chance for participants to get allocated to treatment/control group
how do RCTs minimise confounding variables including unknown confounders big sample with both groups being comparable in all aspects (other than their treatment allocation) eg sex and age
allocation concealment masks the randomisation process before randomisation (Study team and patients no know what group next participant will be randomised to)
allocation concealment prevents what (2) selection bias and confounding
blinding masks allocation of treatment AFTER randomisation (participnts and researchers should not know which treatment is being received)
single blinding one party (participants or investigators) are unaware
double blinding participants and study staff are unaware
open label participants and study staff are aware of allocation/ treatment
blinding prevents ascertainment bias
how does blinding prevents ascertainment bias assessment of the outcome is distorted by the participants and/or researchers
effect of inadequate finding (according to a review) not blinding makes treatment look more effective than it really is (Exaggerated benefits)
potential explanations for findings of observational studies (4) Chance – minimised in an RCT by studying enough people Confounding – removed in an RCT by randomisation and allocation concealment Bias – removed in an RCT by allocation concealment and blinding Truth
well designed large RCT can remove chance, confounding and bias so effect is seen due to intervention (Causation)
how is bias removed in RCT by allocation concealment and blinding
how is confounding removed in RCT removed in an RCT by randomisation and allocation concealment
how is chance removed in RCT – minimised in an RCT by studying enough people
problem with ethical considerations in RCTs - can only test potentially beneficial interventions e.g. can’t test whether smoking causes lung cancer with an RCT.
problem with exploring social factors and demographics in RCTs cant randomise ethnicity, age, poverty, sexuality, educational backgroun
problem with expense and time and logistics in RCTs expensive, sometimes logistically unfeasible and can take long time eg breast feeding and adult onset of diabetes
problem with generalisability in RCT may not be generalisable - controlled nature can be artificial
problem with participants in RCT situations where participants are unwilling to be randomised or are non compliant
problem with selective samples in RCT RCTs often exclude children, elderly, pregnant women, vulnerable populations, people with co-morbidities). Historically, women and BAME people have been under-included
suitable outcome measures are (3) defined in advance, focus on primary hypothesis and outcome, secondary outcome included
why are suitable outcome measures defined in advance What, when and how will outcomes be measured? Prevent ‘data dredging’ (or ‘p-hacking’) Measurements to check for differences between groups at baseline, adverse effects during trial, final measurements to compare effect of treatments
why are suitable outcome measures focused on primary hypothesis and outcome used in sample size calculation - how many study participants do you need to test your hypothesis
why are suitable outcome measures linked to secondary outcomes often includes side effects or sub group analyses
what makes an ideal outcome Appropriate and relevant to patient/clinician; valid, attributable and sensitive to effect of treatment; reliable and robust to different people doing the measuring; simple and cheap to measure. Bear in mind timeliness – may need proxy measures.
attrition bis systematic error where losses to follow-up are related to the study group
how to reduce as much attrition bias as possible Clear information regarding expectations given at recruitment Ensure follow-up schedule is practical and not too onerous
non compliance patients do not follow treatment protocol
how to reduce non compliance as much as possible Clear and simple instructions Checks on compliance e.g. tablet counts at end of study Active monitoring e.g. blood or urine tests
per protocol analysis analyses those who participated in study according to protocol (removes from analysis participants who did not comply with study protocol) - identifies effect which would occur under optimal conditions (true efficacy)
problem with per-protocol analysis (explanatory) no longer protected from confounding effects as non compliers may differ from compliers in non random ways
intention to treat analysis (pragmatic) includes everyone you intended to treat including non compliers in analysis (pragmatic as this is how the world works- real world conditions)
so how should trials be done (explanatory or pragmatic) pragmatic (intention to treat analysis) unless there is good reason to do otherwise
Created by: 22tango
Popular Medical sets

 

 



Voices

Use these flashcards to help memorize information. Look at the large card and try to recall what is on the other side. Then click the card to flip it. If you knew the answer, click the green Know box. Otherwise, click the red Don't know box.

When you've placed seven or more cards in the Don't know box, click "retry" to try those cards again.

If you've accidentally put the card in the wrong box, just click on the card to take it out of the box.

You can also use your keyboard to move the cards as follows:

If you are logged in to your account, this website will remember which cards you know and don't know so that they are in the same box the next time you log in.

When you need a break, try one of the other activities listed below the flashcards like Matching, Snowman, or Hungry Bug. Although it may feel like you're playing a game, your brain is still making more connections with the information to help you out.

To see how well you know the information, try the Quiz or Test activity.

Pass complete!
"Know" box contains:
Time elapsed:
Retries:
restart all cards